The path to eradication of rubella
Susan E Reef1, Joseph P Icenogle2, Stanley A Plotkin3
1Atlanta, GA 30345, USA.
Vaccine
|November 16, 2023
Summary
Rubella vaccination, often combined with measles vaccine, prevents rubella and congenital rubella infection. Global vaccination efforts make rubella eradication feasible with continued infant vaccination and chronic infection surveillance.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Rubella infection during pregnancy causes severe fetal harm.
- The rubella vaccine, available since 1969, is highly effective in preventing rubella and congenital rubella infection.
- Combined measles and rubella vaccines have led to rubella elimination in many regions.
Purpose of the Study:
- To review the feasibility of global rubella eradication.
- To identify potential barriers and strategies for achieving rubella eradication.
Main Methods:
- Review of historical vaccination data.
- Analysis of rubella virus persistence in specific populations.
- Assessment of global vaccination program effectiveness.
Main Results:
- Congenital rubella infection has been eliminated in the Western Hemisphere and most of Europe due to combined vaccination.
- Rubella virus in animals is not a barrier to human rubella eradication.
- Persistent rubella virus in infants and immunosuppressed individuals presents potential challenges.
Conclusions:
- Rubella eradication is feasible with sustained global vaccination efforts.
- Routine infant vaccination and surveillance for chronic rubella infection are crucial for eradication.
- Continued public health initiatives are essential to achieve the elimination of rubella.
Related Concept Videos
Pulmonary Tuberculosis V
181
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
181
Transmission-based Precautions II: Airborne and Protective Environment
1.3K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K
Vaccinations
44.6K
Overview
44.6K
Infection
8.0K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.0K


